Enzolytics CEO: Consumers Actively Searching For Immune Booster Supplements

The global immune booster industry is set to explode in the next decade.

“Dietary supplements have become more trusted and popular with consumers in the past two years because of COVID-19, especially immune system boosters,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas biotech company. “The global immune health supplement sector, according to Fortune Business Insights, is expected to increase from $20.18 billion this year to $31.5 billion by 2028.”

As part of this growing demand from consumers, Mr. Cotropia’s biotech company is about to launch Enzolytics IPF Immune™, which strengthens the body’s immune system.

“We have two factors that are driving the growth of the immune system supplement industry,” Mr. Cotropia said. “First, people are thinking about their health more than ever because of the pandemic.

“Second, millions of consumers take dietary supplements daily,” he added. “In the United States, the Council for Responsible Nutrition’s initial data for 2021 shows 80 percent of Americans now use supplements, a significant 7 percentage point increase from 2020.”

Mr. Cotropia said CRN’s survey results show consumers are flocking to supplements that aid the immune system, such as Vitamins C and D.

“We are introducing Enzolytics IPF Immune™ to consumers at a time when they want to keep their immune system strong, which is why we are participating at ECRM’s “Weight Management, Nutrition, and Vitamin Program” in March.

ECRM brings buyers and brands with new products together for private one-on-one meetings. Buyers attending the ECRM event represent regional and national food, drug and mass health chains.

“We expect great interest from retailers because people want an immune modulator that helps bolster their body’s immune system against infections,” said Harry Zhabilov, the Company CSO. “We are the immune booster supplement for today’s consumers.”

Enzolytics IPF Immune™is a nutritional supplement that is taken orally two consecutive days per week for eight consecutive weeks. The supplement is also gluten-free.

“Consumers today are looking for supplements that strengthen their body’s natural defenses,” Mr. Zhabilov said. “Enzolytics IPF Immune™ is a science-backed immune modulator for people who want to fortify their immune systems.”

For more information, email pr@nutrapr.com or visit enzolytics.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:
Enzolytics, Inc.
2000 North Central Expressway
Plano, TX 75074

Research Center
Enzolytics, Inc.
Texas A&M University
Institute for Preclinical Studies
College Station, TX 77843-44
SOURCE: Enzolytics, Inc.

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.